Tomatoes genetically engineered to produce anthocyanins may be better for you than regular tomatoes
Acid may not be able to turn normal cells in to stem cells. Irregularities surfacing about the recent study claiming it could suggest the data is unreliable.
The lysosome receptor SORLA protein identifies and eliminates misfolded beta-amyloids associated with Alzheimer's plaque formation
The heart has been a symbol of love and desire since ancient times. Take a few minutes on Valentine's Day to tend to both the romantic and physical needs of this critical organ that sustains us.
The high cost of drug development. Why does it cost so much to develop new medicines?
Only about 30 new drugs are approved each year. How are these new drugs identified? From where do companies find the chemicals, antibodies, peptides and other molecules that they test and try to get approved? Also, why is it so expensive to develop new drugs? Discover how new medicines are found. (Posted: Jan 31, 2014)
An increased understanding of disease, escalating healthcare costs and informed patient groups are having a transformative impact on the development and approvals of new therapeutics. What do pharmaceutical and biotech companies need to do to account for these changes to maximize the success of their drug development programs? This summary of a panel discussion at the Biotech Showcase on the Changing Dynamics of the Drug Development Ecosystem provides some insight. (Posted: Jan 22, 2014)
What are the key biomedical developments expected in 2014? What new discoveries are anticipated, or new disease treatments that might pan out? Will the 2013 biotech boom continue? Check out these 6 key stories expected to dominate 2014 biotech news. (Published: January 14, 2014)